Revolution Medicines (RVMD) Competitor Comparison
We are evaluating the key criteria listed to compare Revolution Medicines (RVMD) against its competitors in the Biotechnology industry.
Market Capitalization
34 / 368Gross Profits
263 / 278Total Revenue
146 / 300EBITDA
313 / 337Free Cashflow
318 / 352Quick Ratio
84 / 357Earnings per Share
275 / 359Dividend yield
0 / 6Total Cash
32 / 358Performance 3 years
53 / 368Performance 5 years
71 / 368Performance 10 years
58 / 368Linearity 3 years
331 / 368Linearity 5 years
322 / 368Linearity 10 years
325 / 368Total Rank
250 / 368Dividend Rank
262 / 368Valuation Rank
170 / 368Piotroski Rank
234 / 368Muliplier Rank
195 / 368Performance 3 years - RVMD ranking 53 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.